Altruist's AI head start makes custody choice a technology bet
Schwab's Anthropic deal brings scale and a $240 seat; Altruist's lead is measured in years, and firms switching now are already choosing sides.
Schwab Advisor Services used Future Proof to unveil its exclusive deal with Anthropic and put Claude for Financial Advisors at the center of its pitch to the 16,000 RIAs that use the custodian for custody and back-end services, a rollout RIABiz called a blindside for the soon-to-be Vanguard-owned Altruist. Analysts the publication asked put the challenger's lead at two to five years, with RIABiz's own framing blunter still: five years or more, if Schwab closes the gap at all. It is that estimate, not the announcement, that a firm shopping custody has to price.
The estimate converts a vendor feature fight into a decision about where a practice sits for the rest of the decade, and the analysts priced it accordingly: Alois Pirker, founder and CEO of Pirker Partners, told RIABiz that Altruist's momentum around AI, its positioning as a thought leader in the category and its Vanguard deal amount to a perfect storm for the established custodians. Lex Sokolin, managing partner of the London venture firm Generative Ventures, argued that AI advantages of this kind are cumulative and snowball as the technology accelerates toward winner-take-all outcomes. Analysts dislike being pinned to month counts, as RIABiz noted, and the handful willing to answer still landed on years.
What Arca's switch prices
The first firm to act on the gap appears to be Arca: Jason Wenk, Altruist's founder and CEO, told RIABiz that the $1-billion-plus RIA is leaving Schwab and moving to his platform exclusively, attributing the decision to owners who were reading the technology rather than the fee schedule. Against Schwab's weekly intake a billion dollars is a rounding error, but challengers recruit with reference accounts, and Arca's is the kind that gets shown to the next large firm weighing the same move.
Where the money changes hands matters as much as where the assets sit. As reported this month, Schwab prices the Claude integration at $240 a seat per year, with process work on top, which turns AI into a line item on the custody invoice and leaves the value of the workflow to the advisor's own operations. Altruist sells the platform and treats the tooling as a reason to be on it, optimizing for different things: usage volume at Schwab, switching costs at Altruist. The seat price is the easy part of the arithmetic; the expensive part is the redesign of the work the license lands on, which is why the pre-AI workflow audit this publication has argued for belongs in the custody evaluation rather than after it.
Data is the part of the contest advisors can see least and risk most. RIABiz reports that RIAs are caught in the middle over data concerns as the two sides escalate, and the coverage does not describe what client information moves through Schwab's Anthropic arrangement or on what terms—an omission that is itself a fact. The practical question in a custody evaluation is who holds the record of the meeting, and what the custodian's agreement with a model maker does to it later. Asking that question in writing, while two custodians are still bidding for the business, is the one lever an advisory firm holds.
A transition is often the only moment a practice re-picks its stack, and that stack now includes a model.
Vanguard's pending ownership of Altruist complicates the picture further, and the argument from August still holds: advisors should lock pricing and product independence before the standalone promise expires. If the roadmap is the product, then who owns the roadmap belongs in the same document as the fee schedule, and the two-to-five-year window the analysts described is roughly the life of the decision an owner makes this fall. Schwab has the model, the money and the 16,000 relationships; what an advisory firm controls is narrower—the data language it signs, the pricing it locks, and which platform's AI it will still be living with when the estimate runs out.